Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period
Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...
Clinical Trials Arena on MSN5d
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatment
Imunon has announced the alignment of the FDA with the Phase III OVATION 3 trial of IMNN-001 for ovarian cancer protocol.
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
Morningstar6d
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company's Vision AI Platform
Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.
Fort Worth Star-Telegram5d
Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform
Ainnova has hired an ophthalmologist, who is assisting in drafting the requirements for the clinical trial protocol that the Company's Contract Research Organization (CRO), Fortrea, has requested.